Nanokide TherapeuticsNanokide Therapeutics
  • Home
  • About Nanokide Therapeutics
  • Team
  • Our Technology
  • ‎
  • ARTICLES
  • NEWS
  • AWARDS
  • Contact
  • Our partners and collaborators
  • ⠀
     
    Nanokide TherapeuticsNanokide Therapeutics
      • Home
      • About Nanokide Therapeutics
      • Team
      • Our Technology
      • ‎
      • ARTICLES
      • NEWS
      • AWARDS
      • Contact
      • Our partners and collaborators
      • ⠀

      ‎


      • Album

      •  

        Antiangiogenic therapy

        Mi-20a is a small non-coding RNA downregulated in liver sinusoidal endothelial cells during liver metastasis. Span-based nanoparticles loaded with miR-20a and decorated with chondroitin sulfate can introduce the missing miR-20a specifically in the liver sinusoidal endothelial cells blocking the angiogenic process.

      •  
      •  
      • Home
      • About Nanokide Therapeutics
      • Team
      • Our Technology
      • ‎
      • ARTICLES
      • NEWS
      • AWARDS
      • Contact
      • Our partners and collaborators
      • ⠀
      Copyright © 2025 All rights reserved - Nanokide Therapeutics
      •  +34653700587
      •   nanokide@nanokide.com
      •  
      •